Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
08.08.24
/
50%
€1.41
Target price
08.08.25
€3.21
Performance (%)
-19.66%
End price
09.08.25
€1.13
Summary
This prediction ended on 09.08.25 with a price of €1.13. The price of Pacific Biosciences of California Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.66%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | -4.492% | -4.492% | 10.340% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.50 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€6.27
31.10.23
31.10.23
€10.36
31.10.24
31.10.24
-68.90%
01.11.24
01.11.24
